Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
human mesenchymal stem cells
- Development stage
- Phase 2
- Lead developer
- Landmark Medical Centre
- Modality
- Stem Cell Therapies → Cell Therapies
- Administration
- Intravenous
01
Overview
Human mesenchymal stem cells (hMSCs) are a type of multipotent cell therapy being developed by Landmark Medical Centre for anti-aging and regenerative applications. The treatment involves the intravenous administration of 100 million hMSCs, which are hypothesized to exert therapeutic effects through the secretion of various paracrine factors, including cytokines and growth factors. These factors facilitate tissue repair, reduce systemic inflammation, and modulate the immune system, potentially reversing or slowing the biological markers of aging. Landmark Medical Centre is currently evaluating the safety and efficacy of this infusion in Phase 1 clinical trials involving healthy or stable subjects.
- Other names
- hMSChuman Mesenchymal Stem Cell infusion therapy
Beyond the preview
Go deeper on human mesenchymal stem cells.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on human mesenchymal stem cells.